74.7 F
Clearwater
Saturday, October 24, 2020
news:-rokit-pharma’s-preclinical-studies-showing-tremendous-promise-for-naturally-derived-cancer-drug,-rok-001-–-moving-towards-the-initiation-of-phase-1b/2-clinical-trial

NEWS: ROKiT Pharma’s Preclinical Studies Showing Tremendous Promise for Naturally Derived Cancer Drug, ROK-001...

LOS ANGELES, Calif., Apr 02, 2020 (SEND2PRESS NEWSWIRE) -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural…
news:-lyme-disease-biobank-expands-into-san-diego

NEWS: Lyme Disease Biobank Expands Into San Diego

SAN DIEGO, Calif., Mar 06, 2020 (SEND2PRESS NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from…
news:-icell-gene-therapeutics-announces-car-t-oral-and-poster-presentations-at-61st-american-society-of-hematology-annual-meeting

NEWS: iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society...

STONY BROOK, N.Y., Nov 14, 2019 (SEND2PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of…
news:-hans-van-der-sluijs-joins-biotork-as-chief-development-officer

NEWS: Hans van der Sluijs Joins BioTork as Chief Development Officer

GAINESVILLE, Fla., Oct 30, 2019 (SEND2PRESS NEWSWIRE) -- BioTork, the leading evolution biotechnology company, today announced that biotech executive Hans van der Sluijs has joined the company as Chief Development Officer. Hans brings over 20 years of international business leadership experience, with a focus on business development, management, and building strategic alliances/partnerships. Hans will be…
news:-fifteen-neurotechnology-startups-to-present-at-the-2019-neurotech-leaders-forum-in-san-francisco

NEWS: Fifteen Neurotechnology Startups to Present at the 2019 Neurotech Leaders Forum in San...

SAN FRANCISCO, Calif., Oct 08, 2019 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel…
news:-brandon-stem-cell-clinic-offers-life-changing-treatment-options

NEWS: Brandon Stem Cell Clinic Offers Life-changing Treatment Options

TAMPA, Fla., Aug 12, 2019 (SEND2PRESS NEWSWIRE) -- Brandon Stem Cell Clinic (BSCC) recognizes that osteoarthritis is one of the most common joint conditions, affecting nearly 630 million people worldwide. It is commonly associated with aging but is also frequently seen in cases of overuse of joints. The growing number of cases alone prove a…
3,789FansLike
5,487FollowersFollow
543FollowersFollow
30,600SubscribersSubscribe
Web Hosting

Recent Posts

USD - United States Dollar
EUR
1.186
GBP
1.305
AUD
0.714
HKD
0.129
CHF
1.106
JPY
0.010